Skip to content
#gene editing Open access

Generation and Characterization of an Osteoclastic Cell Model of Gaucher’s Bone Disease

Oct 2026 · Calcified Tissue International · Vol 117 · 0 citations · 22 references
Medicine

TL;DR

Lack of Gba1 activity induced changes in the osteoclast model which enhanced its bone resorption potential, demonstrating a major intrinsic osteoclastic defect in Gaucher disease of bone.

Abstract

Gaucher disease (GD) is caused by recessive mutations in the GBA1 gene (Glucosylceramidase beta 1) generating lysosomal accumulation of glucosylceramides. Bone phenotypes related to GD include Erlenmeyer flask deformity, osteosclerosis, osteonecrosis, osteopenia, and bone pain. Lysosomes modulate osteoclast differentiation, playing a fundamental role in osteoclastogenesis and bone resorption. However, the role of GBA1 mutations in the osteoclast function remains poorly understood. We aimed to generate and characterize an in vitro osteoclast cell model of GD. The Gba1 gene was knocked out with CRISPR/Cas9 in the murine macrophage cell line RAW264.7. One RAW-Gba1KO clone displaying no GBA1 enzymatic activity was selected. Non-edited RAW264.7 cells were used as controls (wt). Expression of osteoclast biomarkers, Rank, Trap, Nfatc1, and pro-cathepsin K/cathepsin K as well as activity of TRAP protein and bone resorption were assessed. RAW-Gba1KO cells showed reduced expression of the osteoclast differentiation markers Rank and Nfatc1, suggesting that osteoclast differentiation is delayed or impaired compared with wt cells. Despite this, KO cells exhibited higher expression of Trap and cathepsin K, indicating enhanced osteoclast activity. Functional assays confirmed this finding, showing significantly increased TRAP activity and bone resorption in KO cells during differentiation. Additionally, KO cells displayed elevated levels of cathepsin K and pro-cathepsin K, particularly before differentiation, which may contribute to the increased TRAP activation. In conclusion, lack of Gba1 activity induced changes in our osteoclast model which enhanced its bone resorption potential, demonstrating a major intrinsic osteoclastic defect in Gaucher disease of bone.

Read PDF

Similar papers

Open access Oct 2026

New insights into bone pathology through a transcriptomic profiling of an osteoblast model of Gaucher disease

Although up to 90% of Gaucher Disease (GD) patients report bone symptoms, the molecular basis underlying the contribution of osteoblasts in bone pathology remains poorly understood. To identify potential molecular players in this process, we developed and characterized a new model of GD osteoblasts by knocking out (KO)...

E. Pavan, Paolo Peruzzo, M. Ormazabal et al. · 0 citations
Oct 2026

3-Methoxychrysazin suppresses RANKL-induced osteoclastogenesis by modulating Notch2 signaling.

Findings indicate that 3-MC mitigates osteoclast differentiation and oxidative stress, accompanied by downregulation of the Notch2 signaling axis, highlighting its potential as a promising therapeutic candidate for bone-related disorders.

D. Lee, Yeo Rang Cho, Ki Hyun Kim et al. · 0 citations
Open access Aug 2026

Urolithin A Alleviates Osteonecrosis and Is Associated With Regulation of SIRT3 in Osteoclasts

Background: Urolithin A (UA) is a safe and promising therapeutic strategy for aging-related disorders, including osteoporosis. Sirtuin 3 (SIRT3) has been reported as a potential modulator of bone-joint pathologies such as osteoclast activation. However, whether UA affects osteoclast activation and function through SIRT...

Yi Xue, Dong-Hua Fan, Pu Ying et al. · 0 citations
Open access Sep 2026

B1486 is a highly potent VprBP inhibitor capable of blocking osteoclast differentiation and bone resorption

Results indicate that B1486 is a highly potent inhibitor for blocking VprBP-mediated H2AT120p and osteoclastogenic gene silencing, as well as for overcoming osteoporosis generated by excessive osteoclast differentiation.

Sungmin Kim, Yonghwan Shin, N. Ghate et al. · 0 citations
Open access Aug 2026

Creation and characterization of novel knock-in mouse models of hypophosphatasia

These knock-in mouse models recapitulate genotype-dependent dental manifestations of HPP and indicate that dental phenotypes are influenced not only by circulating TNAP levels but also by the functional effects of individual ALPL variants.

R. Okawa, Marin Ochiai, H. Kurosaka et al. · 0 citations

Related blog posts

Microsoft Research Blog Nov 12, 2026

Microsoft Research Focus – Edition #98

What's new in research at Microsoft? Host Anson Ho explores the latest, including AI-powered universal translation, a breakthrough in a 31-year-old mathematics challenge, and advances making AI coding agents faster and more efficient.  The post Microsoft Research Focus – Edition #98 appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.